EP2377514A2 — Liquid parenteral formulation comprising a tramadol material and paracetamol
Assigned to Uni Pharma Kleon Tsetis Pharmaceutical Laboratories SA · Expires 2011-10-19 · 15y expired
What this patent protects
The present invention provides a liquid parenterally deliverable formulation comprising a tramadol material, particularly tramadol HCl, and paracetamol and its use in treating conditions or disorder wherein an urgent treatment with analgesics is indicated. This formulation …
USPTO Abstract
The present invention provides a liquid parenterally deliverable formulation comprising a tramadol material, particularly tramadol HCl, and paracetamol and its use in treating conditions or disorder wherein an urgent treatment with analgesics is indicated. This formulation is particularly useful whenever fast relief is required in lesser time, especially in acute or chronic painful conditions. The formulation of the present invention is stable upon storage at room temperature and in refrigerated temperature.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.